首页> Allergy> Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.

Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.

导出 OA

翻译打印收藏纠错

第一作者： Matthew,Plassmeyer

第一单位： Amerimmune, Fairfax, VA, USA.

作者： Matthew,Plassmeyer ^[1] ; Oral,Alpan ^[1] ; Michael J,Corley ^[2] ; Thomas A,Premeaux ^[2] ; Kimberleigh,Lillard ^[1] ; Paige,Coatney ^[1] ; Tina,Vaziri ^[1] ; Suzan,Michalsky ^[1] ; Alina P S,Pang ^[2] ; Zaheer,Bukhari ^[3] ; Stephen T,Yeung ^[2] ; Teresa H,Evering ^[2] ; Gail,Naughton ^[4] ; Martin,Latterich ^[4] ; Philip,Mudd ^[5] ; Alfred,Spada ^[4] ; Nicole,Rindone ^[4] ; Denise,Loizou ^[4] ; Søren,Ulrik Sønder ^[1] ; Lishomwa C,Ndhlovu ^[2] ; Raavi,Gupta ^[3]

作者单位： Amerimmune, Fairfax, VA, USA. ^[1] Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York City, NY, USA. ^[2] S.U.N.Y. Downstate Health Sciences University, Brooklyn, NY, USA. ^[3] Histogen, Inc, San Diego, CA, USA. ^[4] Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO, USA. ^[5]

关键词 COVID-19 T-helper cell caspase emricasan red blood cell

医学主题词 CD4阳性T淋巴细胞(CD4-Positive T-Lymphocytes);半胱氨酸天冬氨酸蛋白酶1(Caspase 1);半胱氨酸天冬氨酸蛋白酶3(Caspase 3);半胱氨酸天冬氨酸蛋白酶7(Caspase 7);半胱氨酸天冬氨酸蛋白酶(Caspases);人类(Humans)

DOI 10.1111/all.14907

PMID 33993490

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交